Advisor Group, Inc. - ACHILLION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$1,000870.0%0.00%
Q3 2019$0870.0%0.00%
Q2 2019$0870.0%0.00%
Q1 2019$0870.0%0.00%
Q4 2018$0870.0%0.00%
Q3 2018$0870.0%0.00%
Q2 2018$0870.0%0.00%
Q1 2018$0
-100.0%
87
-69.7%
0.00%
Q4 2017$1,0000.0%2870.0%0.00%
Q3 2017$1,0000.0%2870.0%0.00%
Q2 2017$1,000
-85.7%
287
-83.9%
0.00%
Q1 2017$7,000
-22.2%
1,787
-18.3%
0.00%
Q4 2016$9,0000.0%2,187
+101.2%
0.00%
Q3 2016$9,000
+125.0%
1,087
+81.2%
0.00%
Q2 2016$4,0006000.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders